Studies have been performed on the biochemical mechanism of platelet activation induced by the fibrinolytic protease plasmin. In washed human platelets, greater than or equal to 1.0 caseinolytic units (CU/ml plasmin induced aggregation. Platelet [14C]serotonin release was stimulated by 1.0 CU/ml plasmin to an extent comparable to that induced by 1.0 U/ml thrombin. A dose- and time-dependent phosphorylation of the platelet 47,000- and 20,000-kD proteins was noted in 32PO4-labeled platelets incubated with plasmin; phosphorylation was not affected by extracellular Ca2+, but was completely inhibited by an increase in platelet cyclic AMP. Phosphorylation of these platelet proteins suggested that plasmin may act on platelets by stimulating a rise in cytosolic calcium concentration ([Cai2+]) and activating inositol phospholipid-dependent phospholipase C and protein kinase C. Using both quin2 fluorescence and aequorin luminescence as indicators, plasmin was found to elevate platelet [Cai2+] in the presence or absence of extracellular Ca2+. Phospholipase C activation was shown by the generation of [3H]diglyceride in [3H]arachidonic acid-labeled platelets and [32P]phosphatidic acid in 32PO4 labeled platelets exposed to plasmin. Plasmin did not induce formation of thromboxane A2 (TXA2). Only small amounts of this eicosanoid were detected late in the time course after plasmin stimulation. Our results indicate that plasmin causes platelet aggregation and secretion associated with phosphorylation of the 47,000- and 20,000-kD proteins, Ca2+ mobilization, and phospholipase C and protein kinase C activation.
A I Schafer, A K Maas, J A Ware, P C Johnson, S E Rittenhouse, E W Salzman
Title and authors | Publication | Year |
---|---|---|
Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases
C Pielsticker, MF Brodde, L Raum, K Jurk, BE Kehrel |
International journal of molecular sciences | 2020 |
Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review
L van der Vorm, J Remijn, B de Laat, D Huskens |
TH Open | 2018 |
Platelets in Thrombotic and Non-Thrombotic Disorders
P Gresele, NS Kleiman, JA Lopez, CP Page |
Platelets in Thrombotic and Non-Thrombotic Disorders | 2017 |
Plasminogen/plasmin influence on platelet aggregation
YM Roka-Moya, DD Zhernossekov, TV Grinenko |
Biopolymers and Cell | 2012 |
Regulation of plasmin-induced protease-activated receptor 4 activation in platelets
Y Mao, J Jin, JL Daniel, SP Kunapuli |
Platelets | 2009 |
Plasmin is involved in inflammation via protease-activated receptor-1 activation in human dental pulp
N Kamio, H Hashizume, S Nakao, K Matsushima, H Sugiya |
Biochemical Pharmacology | 2008 |
Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase
TT Hong, J Huang, BR Lucchesi |
American journal of physiology. Heart and circulatory physiology | 2006 |
A novel mechanism of plasmin-induced mitogenesis in fibroblasts
SK Mandal, LV Rao, TT Tran, UR Pendurthi |
Journal of Thrombosis and Haemostasis | 2005 |
Monitoring platelet function by PFA-100 closure time measurements during thrombolytic therapy of patients with myocardial infarction
A Kerényi, P Soltész, K Veres, G Szegedi, L Muszbek |
Thrombosis Research | 2005 |
Plasmin-induced Migration Requires Signaling through Protease-activated Receptor 1 and Integrin α 9 β 1
M Majumdar, T Tarui, B Shi, N Akakura, W Ruf, Y Takada |
The Journal of biological chemistry | 2004 |
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor
You fu Li, Frederick A Spencer, Richard C Becker |
Journal of Thrombosis and Thrombolysis | 2003 |
Plasmin-induced Migration of Endothelial Cells: A POTENTIAL TARGET FOR THE ANTI-ANGIOGENIC ACTION OF ANGIOSTATIN
T Tarui, M Majumdar, LA Miles, W Ruf, Y Takada |
The Journal of biological chemistry | 2002 |
Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44/42 Mitogen-Activated Protein Kinase–Dependent Signaling Pathway
UR Pendurthi, M Ngyuen, P Andrade-Gordon, LC Petersen, LV Rao |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Platelet activation by sustained exposure to low-dose plasmin
AL Ervin, EI Peerschke |
Blood Coagulation and Fibrinolysis | 2001 |
Platelet activation by sustained exposure to low-dose plasmin:
AL Ervin, EI Peerschke |
Blood Coagulation and Fibrinolysis | 2001 |
On the mechanism of plasmin-induced platelet aggregation Implications of the dual role of granule ADP
A Ishii-Watabe |
Biochemical Pharmacology | 2000 |
Platelets
JN George |
The Lancet | 2000 |
Platelet microparticles: a wide-angle perspective
L Horstman |
Critical Reviews in Oncology/Hematology | 1999 |
The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron
ML Selley, MR Bartlett, AL Czeti, NG Ardlie |
Atherosclerosis | 1998 |
Human platelet activation by thrombolytic agents: Effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression
K Kawano, I Aoki, N Aoki, M Homori, A Maki, Y Hioki, Y Hasumura, A Terano, T Arai, H Mizuno, K Ishikawa* |
American Heart Journal | 1998 |
Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
RL Wilensky |
1998 | |
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD |
The Annals of Thoracic Surgery | 1997 |
High-Molecular-Mass and Low-Molecular-Mass Kininogens Block Plasmin-Induced Platelet Aggregation by Forming a Complex with Kringle 5 of Plasminogen/Plasmin
TE Selim, HR Ghoneim, AB Uknis, RW Colman, RA Cadena |
European Journal of Biochemistry | 1997 |
Aprotinin Inhibits Plasmin-Induced Platelet Activation During Cardiopulmonary Bypass
O Shigeta, H Kojima, T Jikuya, Y Terada, N Atsumi, Y Sakakibara, T Nagasawa, T Mitsui |
Circulation | 1997 |
Platelets and Their Factors
F von Bruchhausen, U Walter |
1997 | |
Plasmin Is a Potent and Specific Chemoattractant for Human Peripheral Monocytes Acting Via a Cyclic Guanosine Monophosphate–Dependent Pathway
T Syrovets, B Tippler, M Rieks, T Simmet |
Blood | 1997 |
Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator
M Yamada, T Horiuchi, T Oribe, S Yamamoto, I Sugie, P A Gentry |
Veterinary Research Communications | 1997 |
The effect of plasmin on platelet function
D Blockmans, H Deckmyn, LV Hove, J Vermylen |
Platelets | 1996 |
Cleavage of the thrombin receptor: identification of potential activators and inactivators
MA Parry, T Myles, J Tschopp, SR Stone |
Biochemical Journal | 1996 |
THE EFFECT OF CHOLESTEROL OXIDATION PRODUCTS ON HUMAN PLATELET AGGREGATION
ML Selley, JA McGuiness, NG Ardlie |
Thrombosis Research | 1996 |
Flow cytometric analysis of the prevention of platelet activation by tissue type plasminogen activator and streptokinase
T Pietrucha, J Golański, Z Baj, H Tchórzewski, J Greger, C Watala |
Fibrinolysis | 1996 |
Plasmin-platelet interaction involves cleavage of functional thrombin receptor
M Kimura, TT Andersen, JW nd, WF Bahou, A Aviv |
American journal of physiology. Cell physiology | 1996 |
Evidence for cAMP-dependent Platelet Ectoprotein Kinase Activity That Phosphorylates Platelet Glycoprotein IV (CD36)
M Hatmi, JM Gavaret, I Elalamy, BB Vargaftig, C Jacquemin |
The Journal of biological chemistry | 1996 |
High Concentrations of Active Plasminogen Activator Inhibitor-1 in Porcine Coronary Artery Thrombi
WP Fay, JG Murphy, WG Owen |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Immunopharmacology of Platelets
MH Kroll, AI Schafer |
Immunopharmacology of Platelets | 1995 |
Streptokinase and APSAC inhibit platelet aggregation in vitro by fibrinogenolysis: Effect of plasma fibrinogen degradation products X and E
J Lebrazi, M Abdelouahed, M Mirshahi, MM Samama, T Lecompte |
Fibrinolysis | 1995 |
Platelets and Platelet Inhibitors in Acute Myocardial Infarction
SG Kamat, NS Kleiman |
Cardiology Clinics | 1995 |
Arterial Thrombosis for the Clinician
RC Becker |
Cardiology Clinics | 1995 |
Improving the efficacy and stability of coronary reperfusion following thrombolysis: Exploring the thrombin hypothesis
RC Becker |
Journal of Thrombosis and Thrombolysis | 1995 |
Achieving optimal reperfusion without adjunctive antithrombotic therapy: Novel thrombolytic dosing strategies
RC Becker |
Journal of Thrombosis and Thrombolysis | 1995 |
Fibrinolysis Inhibits Shear Stress–Induced Platelet Aggregation
SG Kamat, AD Michelson, SE Benoit, JL Moake, D Rajasekhar, JD Hellums, MH Kroll, AI Schafer |
Circulation | 1995 |
Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion
RC Becker |
Clinical Cardiology | 1994 |
Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells
JS Turner, GT Redpath, JE Humphries, SL Gonias, SR Vandenberg |
Biochemical Journal | 1994 |
Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist
BR Lucchessi, WE Rote, EM Driscoll, DX Mu |
British Journal of Pharmacology | 1994 |
Lys-and Glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation
LY Chen, JL Mehta |
Thrombosis Research | 1994 |
The Modern Era of Coronary Thrombolysis
RC Becker |
1994 | |
Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts
M Gonzalez-Gronow, G Gawdi, SV Pizzo |
The Journal of biological chemistry | 1994 |
Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets
MA Orchard, CS Goodchild, CR Prentice, JA Davies, SE Benoit, LJ Creighton-Kemsford, PJ Gaffney, AD Michelson |
British Journal of Haematology | 1993 |
PPACK attenuates plasmin-induced changes in endothelial integrity
LE Rabbani, MT Johnstone, MA Rudd, P Devine, D George, J Loscalzo |
Thrombosis Research | 1993 |
Reciprocating autocatalytic interactions between platelets and the activation system
H Ouimet, J Loscalzo |
Thrombosis Research | 1993 |
The influence of recombinant tissue-type plasminogen activator and plasmin on platelet aggregation: a quenched-flow study
S Dittmar, AR Gear |
Fibrinolysis | 1993 |
Effects of the novel recombinant plasminogen activator BM 06.022 on human platelet aggregation in vitro
U Martin, G Sponer, K Strein |
Fibrinolysis | 1993 |
Fibrinogen degradation products generation is the major determinant of platelet inhibition induced by plasminogen activators in platelet-rich plasma
P Parise, J Hauert, A Iorio, P Callegari, GG Nenci |
Fibrinolysis | 1993 |
Platelet function during thrombolytic therapy with anistreplase
JJ Hoffmann, JJ Bonnier, PG Melman, I Bartholomeus, JE Couvée, R Standring, R Fears |
Fibrinolysis | 1993 |
Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits
G Montrucchio, G Alloatti, F Mariano, E Lupia, PG Lucchina, E Musso, G Emanuelli, G Camussi |
Circulation research | 1993 |
Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells
G Montrucchio, S Bergerone, F Bussolino, G Alloatti, L Silvestro, E Lupia, A Cravetto, MD Leo, G Emanuelli, G Camussi |
Circulation | 1993 |
Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets
MC Shen, CM Teng, A Takada |
1993 | |
Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts
M Gonzalez-Gronow, G Gawdi, SV Pizzo |
The Journal of biological chemistry | 1993 |
“Plasminogen steal” and clot lysis
SR Torr, DA Nachowiak, S Fujii, BE Sobel |
Journal of the American College of Cardiology | 1992 |
Inhibition of cell adhesion by high molecular weight kininogen
S Asakura, RW Hurley, K Skorstengaard, I Ohkubo, DF Mosher |
The Journal of Cell Biology | 1992 |
Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide
RN Puri, CJ Hu, R Matsueda, H Umeyama, RW Colman |
Thrombosis Research | 1992 |
Thrombin antagonists and antiplatelet agents
RC Becker |
The American Journal of Cardiology | 1992 |
Platelet function after in vivo and in vitro treatment with thrombolytic agents
G Bertolino, P Noris, M Previtali, G Gamba, M Ferrario, N Montani, CL Balduini |
The American Journal of Cardiology | 1992 |
Current Concepts in Coronary Thrombolysis
PR Eisenberg |
Hematology/Oncology Clinics of North America | 1992 |
In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis
I Gouin, T Lecompte, MC Morel, J Lebrazi, PW Modderman, C Kaplan, MM Samama |
Circulation | 1992 |
Platelet-dependent thrombin generation after in vitro fibrinolytic treatment
DL Aronson, P Chang, CM Kessler |
Circulation | 1992 |
Streptokinase Inhibits Acute Platelet Thrombus Formation in Stenosed Dog Coronary Arteries
JD Folts, BS Schwartz, MH Kroll, AI Schafer |
Platelets | 1991 |
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor
SR Torr, EJ Haskel, PF VonVoigtlander, SR Bergmann, DR Abendschein |
Journal of the American College of Cardiology | 1991 |
Effect of tranexamic acid on platelet ADP during extracorporeal circulation
G Soslau, J Horrow, I Brodsky |
American Journal of Hematology | 1991 |
Platelets and Fibrinolysis
B Pasche, J Loscalzo |
Platelets | 1991 |
Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics
M Hatmi, B Haye, JM Gavaret, BB Vargaftig, C Jacquemin |
British Journal of Pharmacology | 1991 |
The dependence of activation of platelets by a plasminogen activator on the evolution of thrombin activity
SR Torr, PR Eisenberg, BE Sobel |
Thrombosis Research | 1991 |
Platelet activation in the pathogenesis of unstable angina: Importance in determining the response to plasminogen activators
DJ Fitzgerald |
The American Journal of Cardiology | 1991 |
Recombinant tissue-type plasminogen activator: Current concepts and guidelines for clinical use in acute myocardial infarction. Part II
RC Becker, R Harrington |
American Heart Journal | 1991 |
Effect of intravenous prostaglandin E1 on thrombolysis induced by human recombinant tissue-type plasminogen activator in feline peripheral arterial thrombosis
WR Humphrey, RG Schaub |
Fibrinolysis | 1991 |
Disseminated Intravascular Coagulation: Pathogenesis and Management
AH Schmaier |
Journal of Intensive Care Medicine | 1991 |
Increase in the cytosolic concentration of calcium in platelets of diabetics type II
D Tschöpe, P Rösen, FA Gries |
Thrombosis Research | 1991 |
Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase
KJ Winters, SA Santoro, JP Miletich, PR Eisenberg |
Circulation | 1991 |
Adjuvant antiplatelet strategies in coronary thrombolysis
RC Becker, JM Gore |
Circulation | 1991 |
Effects of Streptokinase and Recombinant Tissue Plasminogen Activator on Platelet Aggregation in Whole Blood
S Heptinstall, DC Berridge, H Judge |
Platelets | 1990 |
Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids
ME Brezinski, CN Serhan |
Proceedings of the National Academy of Sciences | 1990 |
Platelets and Thrombolytic Therapy
JS Flier, LH Underhill, BS Coller |
New England Journal of Medicine | 1990 |
The nature of interactions between tissue-type plasminogen activator and platelets
SR Torr, KJ Winters, SA Santoro, BE Sobel |
Thrombosis Research | 1990 |
Plasminogen receptors in the mediation of pericellular proteolysis
EF Plow, LA Miles |
Cell Differentiation and Development | 1990 |
Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain
RN Puri, FX Zhou, RF Colman, RW Colman |
American journal of physiology. Cell physiology | 1990 |
Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins
MA Rudd, D George, P Amarante, DE Vaughan, J Loscalzo |
Circulation research | 1990 |
Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium
SK Lo, TJ Ryan, N Gilboa, L Lai, AB Malik |
Journal of Clinical Investigation | 1989 |
Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation
DC Berridge, ME Burgess-Wilson, JC Westby, BR Hopkinson, GS Makin |
British Journal of Surgery | 1989 |
Platelet activation by oxidatively modified low density lipoproteins
NG Ardlie, ML Selley, LA Simons |
Atherosclerosis | 1989 |
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator
DJ Fitzgerald, GA Fitzgerald |
Proceedings of the National Academy of Sciences | 1989 |
Attenuation of the inhibitory effect of prostacyclin on platelet function after tissue plasminogen activator or streptokinase infusion in the rabbit
RJ Shebuski, JC Bloom, TS Sellers, T Fujita, B Storer, S Horohonich, KL Fong, EH Ohlstein |
Fibrinolysis | 1989 |
Interactions between pharmacologic concentrations of plasminogen activators and platelets
ET Fry, AM Grace, BE Sobel |
Fibrinolysis | 1989 |
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator
DM Kerins, L Roy, GA FitzGerald, DJ Fitzgerald |
Circulation | 1989 |
Thrombolysis in the Management of Acute Myocardial Infarction and Unstable Angina Pectoris:
J Loscalzo |
Drugs | 1989 |
Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle
M KNORR, R LOCHER, E VOGT, W VETTER, LH BLOCK, F FERRACIN, H LEFKOVITS, A PLETSCHER |
European Journal of Biochemistry | 1988 |
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism
LH Block, M Knorr, E Vogt, R Locher, W Vetter, P Groscurth, BY Qiao, D Pometta, R James, M Regenass |
Proceedings of the National Academy of Sciences | 1988 |
Tissue-type plasminogen activator inhibits aggregation of platelets
T Mizuta, C Imai |
Life Sciences | 1988 |
Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis
LA Miles, EF Plow |
Fibrinolysis | 1988 |
Tissue Plasminogen Activator
JA Oates, AJ Wood, J Loscalzo, E Braunwald |
New England Journal of Medicine | 1988 |
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction
DJ Fitzgerald, F Catella, L Roy, GA FitzGerald |
Circulation | 1988 |
Tissue plasminogen activator promotes platelet disaggregation in plasma
J Loscalzo, DE Vaughan |
Journal of Clinical Investigation | 1987 |
Impaired thromboxane synthesis in preactivated human blood platelets: Agonist-specific, irreversible desensitization to thrombin
HJ Reimers, RK Baker, JH Joist |
Thrombosis Research | 1987 |
Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit
EH Ohlstein, B Storer, T Fujita, RJ Shebuski |
Thrombosis Research | 1987 |